PFM Health Sciences, LP - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2014$14,721,000
-25.5%
850,942
-23.6%
0.29%
-17.9%
Q1 2014$19,771,000
-29.9%
1,114,462
-27.6%
0.36%
-36.9%
Q4 2013$28,184,000
+39.0%
1,540,091
+67.3%
0.57%
+16.2%
Q3 2013$20,275,000
-16.5%
920,591
-30.1%
0.49%
-3.4%
Q2 2013$24,287,000
+146.1%
1,316,357
+114.8%
0.50%
+54.4%
Q1 2013$9,868,000612,9060.33%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Allegis Investment Advisors, LLC 342,709$569,0000.29%
GENERAL AMERICAN INVESTORS CO INC 396,123$638,0000.07%
Alambic Investment Management, L.P. 69,191$111,0000.03%
Acrospire Investment Management LLC 15,119$24,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 98,486$158,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,030$507,0000.01%
SIMPLEX TRADING, LLC 86,054$138,0000.01%
A.R.T. Advisors, LLC 34,315$55,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$18,0000.00%
Renaissance Technologies 561,713$904,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders